DK3324937T3 - Brugsfærdig bortezomib-opløsning - Google Patents

Brugsfærdig bortezomib-opløsning Download PDF

Info

Publication number
DK3324937T3
DK3324937T3 DK16744351.4T DK16744351T DK3324937T3 DK 3324937 T3 DK3324937 T3 DK 3324937T3 DK 16744351 T DK16744351 T DK 16744351T DK 3324937 T3 DK3324937 T3 DK 3324937T3
Authority
DK
Denmark
Prior art keywords
ready
bortezomib solution
solution
use bortezomib
bortezomib
Prior art date
Application number
DK16744351.4T
Other languages
English (en)
Inventor
Edgar Schridde
Original Assignee
Stada Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53719596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3324937(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stada Arzneimittel Ag filed Critical Stada Arzneimittel Ag
Application granted granted Critical
Publication of DK3324937T3 publication Critical patent/DK3324937T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK16744351.4T 2015-07-22 2016-07-21 Brugsfærdig bortezomib-opløsning DK3324937T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15002163.2A EP3120836A1 (de) 2015-07-22 2015-07-22 Gebrauchsfertige bortezomib-lösung
PCT/EP2016/067413 WO2017013208A1 (de) 2015-07-22 2016-07-21 Gebrauchsfertige bortezomib-lösung

Publications (1)

Publication Number Publication Date
DK3324937T3 true DK3324937T3 (da) 2022-11-14

Family

ID=53719596

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16744351.4T DK3324937T3 (da) 2015-07-22 2016-07-21 Brugsfærdig bortezomib-opløsning

Country Status (8)

Country Link
EP (3) EP3120836A1 (da)
KR (2) KR20180033247A (da)
DE (2) DE202016008851U1 (da)
DK (1) DK3324937T3 (da)
ES (1) ES2895772T3 (da)
PT (1) PT3324937T (da)
RS (1) RS63736B1 (da)
WO (1) WO2017013208A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3120837A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Verfahren zur herstellung einer bortezomibester-lösung
EP3120836A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Gebrauchsfertige bortezomib-lösung
WO2020144607A1 (en) * 2019-01-11 2020-07-16 Intas Pharmaceuticals Ltd. A process for preparation of a stable pharmaceutical composition of bortezomib
US11986486B2 (en) 2020-11-02 2024-05-21 Spes Pharmaceuticals Inc. Aqueous compositions of bortezomib
US20230104074A1 (en) 2021-09-24 2023-04-06 MAIA Pharmaceuticals, Inc. Bortezomib compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913386A (en) 1956-03-21 1959-11-17 Jr Leland C Clark Electrochemical device for chemical analysis
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US6274169B1 (en) 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
JP4162491B2 (ja) 2001-01-25 2008-10-08 アメリカ合衆国 ボロン酸化合物製剤
CA2727862C (en) 2008-06-17 2016-04-19 Millennium Pharmaceuticals, Inc. Boronate ester compounds and pharmaceutical compositions thereof
NZ602392A (en) 2010-03-18 2014-03-28 Innopharma Inc Stable bortezomib formulations
KR101069128B1 (ko) 2011-03-10 2011-09-30 건일제약 주식회사 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법
US10293048B2 (en) * 2012-03-02 2019-05-21 Dr. Reddy's Laboratories Limited Pharmaceutical compositions comprising boronic acid compounds
CA2784240C (en) * 2012-03-27 2014-07-08 Innopharma, Inc. Stable bortezomib formulations
EA021179B1 (ru) 2012-06-15 2015-04-30 Ощество С Ограниченной Ответственностью "Тева" Лиофилизат соединения бороновой кислоты
JP6165986B2 (ja) * 2013-08-23 2017-07-19 シントン・ビー．ブイ．Ｓｙｎｔｈｏｎ Ｂ．Ｖ． ボルテゾミブを含む医薬組成物
EP3120836A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Gebrauchsfertige bortezomib-lösung

Also Published As

Publication number Publication date
EP4101441A1 (de) 2022-12-14
ES2895772T3 (es) 2022-11-17
ES2895772T1 (es) 2022-02-22
KR20250010130A (ko) 2025-01-20
DE202016009131U1 (de) 2022-08-15
EP3324937B1 (de) 2022-08-17
EP3324937A1 (de) 2018-05-30
DE202016008851U1 (de) 2020-03-09
EP3120836A1 (de) 2017-01-25
KR20180033247A (ko) 2018-04-02
PT3324937T (pt) 2022-10-28
WO2017013208A1 (de) 2017-01-26
RS63736B1 (sr) 2022-12-30

Similar Documents

Publication Publication Date Title
IL282123A (en) Solid solution compositions
DK3555933T3 (da) Grænseflade til batterienhed
HUE061287T2 (hu) Újratöltõ csomag e-cigarettához
HUE055465T2 (hu) PD-L1 ellenes humán antitestek
HUE060353T2 (hu) Pridopidin alkalmazása memória javítására
PL3509156T3 (pl) Roztwór elektrolitu
PT3094237T (pt) Eletrocardiógrafo
LT3149345T (lt) Būdas dviem objektams sujungti
DK3341303T3 (da) Blisterpakning
DK3201206T3 (da) Borsyrederivater
EP2961397A4 (en) TRANSDERMAL FORMULATIONS
DK3363428T3 (da) Perfusionsdoseringsform
IL250649A0 (en) Topical composition containing ranpirnase
CL2016001687A1 (es) Colorante-polímero
PL3145592T3 (pl) Kompozycja do pielęgnacji skóry
DK3324937T3 (da) Brugsfærdig bortezomib-opløsning
HUE047455T2 (hu) HPA-1A elleni antitestek
DK3148513T3 (da) Ceritinib-formulering
DK3193856T3 (da) Formulering
PL3166594T3 (pl) Sposób wytwarzania preparatów do inhalacji
TH1601003836A (th) วิธีผลิตสารละลายน้ำตาล
TH1601002523B (th) วิธีการสร้างวัตถุ
TH1601000944A (th) วิธีผลิตสารละลายน้ำตาล
TH1501005117A (th) วิธีผลิตสารละลายน้ำตาล
TH1501004636A (th) วิธีผลิตสารละลายน้ำตาล